(19)
(11) EP 4 514 839 A1

(12)

(43) Date of publication:
05.03.2025 Bulletin 2025/10

(21) Application number: 23718338.9

(22) Date of filing: 17.03.2023
(51) International Patent Classification (IPC): 
C07K 14/82(2006.01)
A61P 19/00(2006.01)
 C12N 15/63(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 14/82; C12N 15/63; A61P 19/00; C12N 2800/22; C12N 2740/16043; C12N 2830/15
(86) International application number:
PCT/IB2023/052649
(87) International publication number:
WO 2023/175585 (21.09.2023 Gazette 2023/38)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 17.03.2022 US 202263269514 P
17.03.2022 US 202263269517 P

(71) Applicant: Innoskel
06410 Biot (FR)

(72) Inventors:
  • GOUZE, Elvire
    06410 Biot (FR)
  • FAVRE, David
    06410 Biot (FR)
  • SARRAZY GARCIA, Stéphanie
    06410 Biot (FR)

(74) Representative: Lavoix 
2, place d'Estienne d'Orves
75441 Paris Cedex 09
75441 Paris Cedex 09 (FR)

   


(54) HYBRID PROMOTERS AND THEIR USE IN OSTEOLYSIS SYNDROME